The Stochastic Oscillator for BMI moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 63 similar instances where the indicator exited the overbought zone. In 40 of the 63 cases the stock moved lower. This puts the odds of a downward move at 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Aroon Indicator for BMI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 58 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on October 09, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 183 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.597) is normal, around the industry mean (1.792). P/E Ratio (30.665) is within average values for comparable stocks, (7.746). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.013) settles around the average of (0.011) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for TRMB turned positive on October 06, 2026. Looking at past instances where TRMB's MACD turned positive, the stock continued to rise in 34 of 52 cases over the following month. The odds of a continued upward trend are 65%.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on TRMB as a result. In 50 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
TRMB moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TRMB crossed bullishly above the 50-day moving average on October 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +4.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRMB advanced for three days, in 196 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
TRMB broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TRMB entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.856) is normal, around the industry mean (1.792). TRMB has a moderately low P/E Ratio (-130.396) as compared to the industry average of (7.746). Projected Growth (PEG Ratio) (1.355) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.589) is also within normal values, averaging (32.028).
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. TRMB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
BMI | TRMB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 86 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 75 Overvalued | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 84 | 100 | |
SMR RATING 1..100 | 49 | 91 | |
PRICE GROWTH RATING 1..100 | 58 | 45 | |
P/E GROWTH RATING 1..100 | 74 | 99 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TRMB's Valuation (7) in the Telecommunications Equipment industry is significantly better than the same rating for BMI (75) in the Electronic Equipment Or Instruments industry. This means that TRMB’s stock grew significantly faster than BMI’s over the last 12 months.
BMI's Profit vs Risk Rating (84) in the Electronic Equipment Or Instruments industry is in the same range as TRMB (100) in the Telecommunications Equipment industry. This means that BMI’s stock grew similarly to TRMB’s over the last 12 months.
BMI's SMR Rating (49) in the Electronic Equipment Or Instruments industry is somewhat better than the same rating for TRMB (91) in the Telecommunications Equipment industry. This means that BMI’s stock grew somewhat faster than TRMB’s over the last 12 months.
TRMB's Price Growth Rating (45) in the Telecommunications Equipment industry is in the same range as BMI (58) in the Electronic Equipment Or Instruments industry. This means that TRMB’s stock grew similarly to BMI’s over the last 12 months.
BMI's P/E Growth Rating (74) in the Electronic Equipment Or Instruments industry is in the same range as TRMB (99) in the Telecommunications Equipment industry. This means that BMI’s stock grew similarly to TRMB’s over the last 12 months.
| BMI | TRMB | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 63% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 60% | 2 days ago 62% |
| Declines ODDS (%) | 4 days ago 58% | 15 days ago 72% |
| BollingerBands ODDS (%) | N/A | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 58% | 2 days ago 76% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMI’s FA Score shows that 0 FA rating(s) are green while TRMB’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMI’s TA Score shows that 4 TA indicator(s) are bullish while TRMB’s TA Score has 5 bullish TA indicator(s).
BMI (@Electronic Equipment/Instruments) experienced а +2.65% price change this week, while TRMB (@Electronic Equipment/Instruments) price change was +5.91% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -3.39%. For the same industry, the average monthly price growth was -13.90%, and the average quarterly price growth was -16.41%.
BMI is expected to report earnings on Oct 22, 2026.
TRMB is expected to report earnings on Nov 04, 2026.
This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
A.I.dvisor indicates that over the last year, TRMB has been loosely correlated with VNT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TRMB jumps, then VNT could also see price increases.
| Ticker / NAME | Correlation To TRMB | 1D Price Change % | ||
|---|---|---|---|---|
| TRMB | 100% | +0.76% | ||
| VNT - TRMB | 43% Loosely correlated | +0.47% | ||
| FTV - TRMB | 39% Loosely correlated | +0.48% | ||
| ITRI - TRMB | 35% Loosely correlated | +0.46% | ||
| GRMN - TRMB | 35% Loosely correlated | +0.27% | ||
| BKSY - TRMB | 34% Loosely correlated | +2.85% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IWL | 192.23 | 1.16 | +0.61% |
| iShares Russell Top 200 ETF (IWL) | |||
| DDTY | 20.87 | 0.06 | +0.31% |
| Innovator Equity Dual Directional 10 Buffer ETF - MAY (DDTY) | |||
| GMAR | 45.49 | 0.05 | +0.11% |
| FT Vest U.S. Equity Moderate Buffer ETF - March (GMAR) | |||
| MBBB | 20.35 | N/A | +0.02% |
| VanEck Moody's Analytics BBB Corporate Bond ETF (MBBB) | |||
| BBP | 104.94 | -0.86 | -0.82% |
| Virtus Biotech ETF (BBP) | |||